Evidence map›Paper›PMID 40736752›Full record

ArticleClinical and experimental medicine2025

Identification of DNA damage response and crotonylation-related biomarkers for lung adenocarcinoma via machine learning and WGCNA.

Kandi Xu, Yayi He

Abstract read
In one paragraph

Article in Clinical and experimental medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Comprehensive analysis ofJournal of thoracic disease · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Kandi XuSchool of Medicine, Tongji University, Shanghai, 200092, China.
Yayi HeSchool of Medicine, Tongji University, Shanghai, 200092, China. yayi.he@tongji.edu.cn.

Funding

Clinical Research Project of Shanghai Pulmonary Hospital FKLY20010'Dream Tutor' Outstanding Young Talents Program fkyq1901National Key Research and Development Program of China 2022YFF0705300National Natural Science Foundation of China 52272281Shanghai Municipal Science and Technology Major Project 2021SHZDZX0100Young Talents in Shanghai 2019 QNBJ
6 · The paper itself

Abstract

DNA damage response (DDR) and crotonylation occur frequently in lung adenocarcinoma (LUAD), but their relationship is yet to be elucidated. RNA sequencing data from LUAD patients in GSE27262 and GSE140797 datasets were obtained. DDR-crotonylation-related differentially expressed genes were identified by differential analysis and weighted gene co-expression network analysis. Three machine learning algorithms were used to screen for foremost ones. Various analyses such as immune infiltration, genetic mutation, and drug sensitivity were carried out based on multiple databases and cytotoxicity tests. Three hub genes were extracted with the potential as diagnostic and predictive criteria. They were also related to immune infiltration, immune checkpoint expression and genome heterogeneity of LUAD. Additionally, drug sensitivity analysis pinpointed probable small molecule inhibitors targeting our hub genes. This study confirmed the activation of DDR and crotonylation in LUAD, which is characterized by abnormal expressions of the hub genes, and translated it into clinical applications. We also overviewed the relationships among those specific molecular features, metabolic reprogramming and immune evasion.

Indexed as

Adenocarcinoma of LungBiomarkers, TumorDNA DamageLung NeoplasmsMachine LearningComputational BiologyGene Expression ProfilingGene Expression Regulation, NeoplasticGene Regulatory NetworksHumansBiomarkers, TumorCrotonylationDNA damage responseLung adenocarcinomaMachine learningWeighted gene co-expression network analysis

Identifiers

PMID40736752
PMCPMC12310847

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.